Aktuellt
SENASTE
Vitrolife continues stabilise its growth rate and is approaching high single-digit growth. The Q4 6% outcome is still far from the long-term objective of >10% but is another step in the right direction. Strong areas include EMEA, Americas, Consumables and Technologies. Together with a positive gross margin surprise, this will likely trigger a positive share price reaction.
LÄS MER
